Bio-Rad Laboratories Profit Margin

As of the most recent data (June 2026), BIO shows a profit margin of 8.59%. That compares with 9.99% in the prior-year period — down 14.0% year over year. That is below the Healthcare sector average of 13.89%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIO's profit margin is now 8.59% (was 9.99%) — a 14.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bio-Rad Laboratories is outperforming or lagging.

The Healthcare sector average profit margin is about 13.89%. Bio-Rad Laboratories is at 8.59%, which is lower that average. That is roughly 38.2% below the sector mean. Use the comparison chart on this page to see how BIO stacks up against individual peers as well.

That compares with 9.99% in the prior-year period — down 14.0% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Bio-Rad Laboratories with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Bio-Rad Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 8.59%) with ownership activity and broader fundamentals.